Clobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDC 52565-039-60
Published December 9, 2020 · Recall initiated: November 5, 2020
Summary
FDA records drug Class III recall D-0119-2021, published December 9, 2020 and initiated November 5, 2020. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 20160 tubes; Lot: Lot Number: 12597, exp. date 12/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent and Subpotent; low and high assay results
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teligent Pharma, Inc.
- Distributor
- Nationwide
- Lot
- Lot Number: 12597, exp. date 12/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATriamcinolone Acetonide Cream USP, 0.1%, packaged in a) 15 grams tubes, NDC 52565-056-15; b) 30 grams tubes,March 30, 2022
- FDADesoximetasone Ointment USP, 0.25%, packaged in a) 100 grams tubes, NDC 52565-030-99; b) 60 grams tubes, NDCMarch 30, 2022
- FDATriamcinolone Acetonide Ointment USP, 0.5%, Net Wt. 15 grams tube, Rx Only, Teligent Pharma, Inc., Buena, NewMarch 30, 2022
- FDALidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co.,March 30, 2022
- FDAREGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPMDecember 9, 2020
- FDAAnagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., BaskingDecember 9, 2020
Questions about this recall
Was Clobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDC 52565-039-60 recalled?
Yes. FDA published recall D-0119-2021 on December 9, 2020. Reported hazard: Superpotent and Subpotent; low and high assay results
What should I do if I have this product?
Voluntary: Firm initiated · Letter